Last update 08 May 2025

NM57S/NC08

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Target
RABV-G
Action
inhibitors
Mechanism
RABV-G inhibitors(RABV-G inhibitors), Rabies virus neutralization
Therapeutic Areas
Infectious DiseasesOther Diseases
Active Indication
Rabies
Inactive Indication-
Originator Organization
North China Pharmaceutical Co., Ltd.North China Pharmaceutical Co., Ltd.
Active Organization
NCPC New Drug Research & Development Co. Ltd.NCPC New Drug Research & Development Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with NM57S/NC08
CTR20251420
/ Not yet recruitingPhase 3
一项随机、盲法、阳性对照（HRIG）设计评价NM57S/NC08注射液组合制剂与人用狂犬病疫苗联合用于Ⅲ级狂犬病暴露人群的 有效性和安全性的Ⅲ期临床试验
[Translation] A randomized, blinded, positive-controlled (HRIG) phase III clinical trial to evaluate the efficacy and safety of NM57S/NC08 injection combination preparation combined with human rabies vaccine in people exposed to level III rabies
CTR20200829
/ CompletedPhase 1/2
组合制剂在健康志愿者中随机、对照的耐受性、安全性、药代动力学、中和抗体活性和免疫原性临床试验
[Translation] A randomized, controlled clinical trial of the tolerability, safety, pharmacokinetics, neutralizing antibody activity, and immunogenicity of the combination in healthy volunteers
100 Clinical Results associated with NM57S/NC08
Login to view more data
100 Translational Medicine associated with NM57S/NC08
Login to view more data
100 Patents (Medical) associated with NM57S/NC08
Login to view more data
100 Deals associated with NM57S/NC08
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
RabiesPhase 3
China
NCPC New Drug Research & Development Co. Ltd.NCPC New Drug Research & Development Co. Ltd.
16 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free